1/30
07:27 am
lptx
Leap Therapeutics, Inc. (NASDAQ: LPTX) was downgraded by analysts at Baird R W from a "strong-buy" rating to a "hold" rating.
Medium
Report
Leap Therapeutics, Inc. (NASDAQ: LPTX) was downgraded by analysts at Baird R W from a "strong-buy" rating to a "hold" rating.
1/29
08:06 am
lptx
Leap Therapeutics, Inc. (NASDAQ: LPTX) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating. They now have a $1.25 price target on the stock, down previously from $9.00.
High
Report
Leap Therapeutics, Inc. (NASDAQ: LPTX) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating. They now have a $1.25 price target on the stock, down previously from $9.00.
1/29
08:06 am
lptx
Leap Therapeutics, Inc. (NASDAQ: LPTX) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating.
High
Report
Leap Therapeutics, Inc. (NASDAQ: LPTX) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating.
1/16
07:44 am
lptx
Leap Therapeutics, Inc. (NASDAQ: LPTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.50 price target on the stock.
High
Report
Leap Therapeutics, Inc. (NASDAQ: LPTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.50 price target on the stock.
1/6
07:00 am
lptx
Leap Therapeutics to Participate at the 43rd Annual J.P. Morgan Healthcare Conference
High
Report
Leap Therapeutics to Participate at the 43rd Annual J.P. Morgan Healthcare Conference
11/26
07:00 am
lptx
Leap Therapeutics to Participate at Piper Sandler 36th Annual Healthcare Conference
Medium
Report
Leap Therapeutics to Participate at Piper Sandler 36th Annual Healthcare Conference